Researchers use several strategies to manage patient heterogeneity:
Stratification: Patients are grouped based on specific characteristics such as cancer type, stage, or genetic markers to ensure more homogeneous study populations. Personalized medicine: Treatments are tailored to the individual characteristics of each patient, often based on genetic profiling. Adaptive trial designs: These allow for modifications to the trial procedures based on interim results, helping to address variability and improve efficiency.
